+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinoic Acid Receptor Alpha"

Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Retinoic acid receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Retinoic acid receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020 - Product Thumbnail Image

Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020

  • Drug Pipelines
  • April 2020
  • 76 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Retinoic Acid Receptor Alpha (RARα) market is a segment of the genomics industry that focuses on the development of products and services related to the RARα gene. RARα is a nuclear receptor that plays a role in the regulation of gene expression and is involved in a variety of biological processes, including cell differentiation, development, and metabolism. It is also involved in the regulation of the immune system and is a potential target for the development of new drugs. The RARα market is composed of a variety of companies, including biotechnology and pharmaceutical companies, as well as research institutions and universities. Companies in the market are focused on developing products and services related to RARα, such as diagnostic tests, therapeutic drugs, and research tools. Examples of companies in the RARα market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, and Pfizer. Show Less Read more